High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin

Cancer Genetics and Cytogenetics

Volumn 97, Issue 2, 1997, Pages 114-118

  Liang, Raymond ^a,b   Chan, W P ^a   Kwong, Y L ^a   Xu, W S ^a   Srivastava, G ^a   Ho, Faith C S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CLONAL ANERGY; FEMALE; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC CODE; HUMAN; INCIDENCE; LARGE CELL LYMPHOMA; MALE; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

ADULT; AGED; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS;

EID: 0030746280     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00388-3     Document Type: Article

References (25)

1. Ho FCS, Todd D, Loke SL, Ng RP, Khoo RKK (1984): Clinicopathological features of malignant lymphoma in 294 Hong Kong Chinese patients - retrospective study covering an eight-year period. Int J Cancer 34:143-148.
2. Xu WS, Ho FCS, Ho J, Chan ACL, Srivastava G (1996): Pathogenesis of gastric lymphoma: the enigma in Hong Kong. Ann Onco 7:10.
3. Kerchaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C (1993): LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocation in human lymphomas. Nature Genet 5:66-70.
4. Baron BW, Nucifora G, McCabe N, Espinosa R III, LeBeau MM, McKeithan TW (1993): Identification of the gene associated with the recurring chromosomal translocation t(3;14) (q27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA 90:5262-5266.
5. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R (1993): Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747-750.
6. Miki T, Kawamata N, Hirosawa S, Aoki N (1994): Gene involved in the 3q27 translocation associated with B-cell lymphoma. BCL5, encodes a Krüppel-like zinc-finger protein. Blood 83:26-32.
7. Offit K, Lo Coco F, Louie DC, Parsa NZ, Leung D, Portlock C, Ye BH, Lista F, Filippa DA, Rosenbaum A, Ladanyi M, Jhanwar S, Dalla-Favera R, Chaganti RSK (1994): Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 331:74-80.
8. Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Fezella F, Fruchart C, Duval C, Monconduit M, Tilly H (1994): LA23 rearrangements in nonHodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83:2423-2427.
9. Lo Coco F, Ye BH, Lista F, Carradini P, Offit K, Knowles DM, Chaganti RSK, Dalla-Favera R (1994): Rearrangements of the BCL-6 gene in large cell nonHodgkin's lymphoma. Blood 83:1757-1759.
10. The non-Hodgkin's Lymphoma Pathologic Classification Project (1982): NCI sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 49:2112-2135.
11. Ho FCS, Loke SL, Hui PK, Todd D (1986): Immunohistological subtypes of nonHodgkin's lymphoma in Hong Kong Chinese. Pathology 18:426-430.
12. Carbone PP, Kaplan HS, Mushoff K, Smithier DW, Tubiana M (1971): Report of the Committee on Hodgkin's disease staging. Cancer Res 31:1860-1861.
13. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993): a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994.
14. Hoogstraten B (1984): Reporting treatment results in solid tumors. In: Cancer Clinical Trials, Methods and Practice. ME Buyse, MJ Staquet, RJ Sylvester, eds. Oxford University Press, Oxford, pp. 139-156.
15. Kaplan EL, Meier P (1958): Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481.
16. DeVita VT, Serpick AA, Carbone PP (1970): Combination chemotherapy in the treatment of Hodgkin's disease. Ann Intern Med 73:881-886.
17. McKelvey EM, Gottlieb JA, Wilson HE (1976): Hydroxydaunorubicin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:1484-1490.
18. Schein PS, DeVita VT Jr, Hubbard S (1976): Bleomycin, adriamycin, cyclophosphamide, vincristine and prednisone (BACOP) combination chemotherapy in the treatment of advanced aggressive histiocytic lymphomas. Ann Intern Med 85:417-422.
19. Shipp MA, Harrington DP, Klatt MM (1986): Identification of major prognostic subgroups of patients with diffuse large cell lymphomas treated with m-BACOD of M-BACOD. Ann Intern Med 104:757-763.
20. Cabanillas PP, Hagemeister FB, Bodey GP, Freireich EF (1982): IMVP-16, an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 60:693-697.
21. Liang R, Chan WP, Chan ACL, Ho FCS (1996): Rearrangement of bcl-6 gene in Hodgkin's disease, lymphocyte predominant type. Am f Hematol (in press).
22. Liang R, Todd D, Chan TK, Chiu E, Lie A, Kwong YL, Choy D, Ho FCS (1995): Prognostic factors for primary gastrointestinal lymphoma. Hematol Oncol 13:153-163.
23. Isaacson PC (1990): Lymphomas of mucosa associated lymphoid tissue (MALT). Histopathology 16:617-619.
24. Cavalli F, Roggero E, Zucca E (1996): Treatment of gastric lymphoma. Ann Oncol 7:3.
25. Wotherspoon AC, Doglioni C, Diss TC (1993): Regression of primary low grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Heliobacter pylori. Lancet 342:375-577.